- Home
- BCYC vs PMI Comparison
BCYC vs PMI Comparison
Compare BCYC & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- PMI
- Stock Information
- Founded
- BCYC 2009
- PMI 1981
- Country
- BCYC United Kingdom
- PMI United States
- Employees
- BCYC N/A
- PMI N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- PMI
- Sector
- BCYC Health Care
- PMI
- Exchange
- BCYC Nasdaq
- PMI Nasdaq
- Market Cap
- BCYC 565.5M
- PMI 605.1M
- IPO Year
- BCYC 2019
- PMI 2025
- Fundamental
- Price
- BCYC $8.76
- PMI $3.28
- Analyst Decision
- BCYC Buy
- PMI
- Analyst Count
- BCYC 11
- PMI 0
- Target Price
- BCYC $22.91
- PMI N/A
- AVG Volume (30 Days)
- BCYC 284.7K
- PMI 3.5M
- Earning Date
- BCYC 10-31-2025
- PMI 12-16-2025
- Dividend Yield
- BCYC N/A
- PMI N/A
- EPS Growth
- BCYC N/A
- PMI N/A
- EPS
- BCYC N/A
- PMI N/A
- Revenue
- BCYC $19,281,000.00
- PMI $4,461,000.00
- Revenue This Year
- BCYC N/A
- PMI N/A
- Revenue Next Year
- BCYC N/A
- PMI N/A
- P/E Ratio
- BCYC N/A
- PMI N/A
- Revenue Growth
- BCYC N/A
- PMI 1.36
- 52 Week Low
- BCYC $6.10
- PMI $3.03
- 52 Week High
- BCYC $25.39
- PMI $13.68
- Technical
- Relative Strength Index (RSI)
- BCYC 56.40
- PMI N/A
- Support Level
- BCYC $7.65
- PMI N/A
- Resistance Level
- BCYC $8.75
- PMI N/A
- Average True Range (ATR)
- BCYC 0.45
- PMI 0.00
- MACD
- BCYC -0.03
- PMI 0.00
- Stochastic Oscillator
- BCYC 55.56
- PMI 0.00
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.